Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple primary malignant neoplasms.

S S Lee, B K Wasiljew, K T Song

    Journal of Surgical Oncology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    A 75-year-old man experienced multiple synchronous neoplasms, including breast cancer. Long-term stilbestrol treatment for prostate cancer may have contributed to the breast cancer development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reactive navigation in dynamic environment using a multisensor predictor.

    IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society·2008
    Same author

    Synthesis and oral antitumor activity of tetrakis(carboxylato)platinum(IV) complexes.

    Journal of medicinal chemistry·2001
    Same author

    Vascularized island pedicle iliac bone grafting for avascular necrosis of the femoral head.

    Chang Gung medical journal·2000
    Same author

    New jujubogenin glycosides from Colubrina asiatica.

    Journal of natural products·2000
    Same author

    Poor compliance with postmolar surveillance and treatment protocols by indigent women.

    Obstetrics and gynecology·2000
    Same author

    Cyclopeptide alkaloids from Paliurus ramossisimus.

    Journal of natural products·2000
    Same journal

    The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

    Journal of surgical oncology·2026
    Same journal

    "It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

    Journal of surgical oncology·2026
    Same journal

    A Tale of Two Pathways: Same-Surgeon Versus Different-Surgeon Resection After Second Surgical Opinion.

    Journal of surgical oncology·2026
    Same journal

    How I Do It: The Life and Work of a Rubber Band in Robotic Liver Parenchymal Transection.

    Journal of surgical oncology·2026
    Same journal

    New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery.

    Journal of surgical oncology·2026
    Same journal

    Performance of Survival Prediction Tools in Patients With Gastrointestinal Stromal Tumors: A Systematic Review and Meta-Analysis.

    Journal of surgical oncology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Neoplasia
    • Medical History

    Background:

    • This case highlights the complexity of metachronous neoplasms in a single patient.
    • It examines the potential long-term effects of hormonal therapies on cancer development.

    Observation:

    • A 75-year-old male patient presented with a history of neurilemmoma, colon polyp, prostate adenocarcinoma, lymphoma, and breast carcinoma over 38 years.
    • The breast cancer diagnosis followed 7 years of stilbestrol treatment for prostate cancer.

    Findings:

    • The patient developed five distinct primary cancers over nearly four decades.
    • A potential causal link is suggested between stilbestrol therapy for prostate cancer and subsequent breast carcinoma.

    Implications:

    Related Experiment Videos

    • This case underscores the importance of long-term surveillance for patients with a history of multiple cancers.
    • It raises awareness regarding the potential oncogenic risks associated with hormonal treatments, particularly stilbestrol.